RPS Pharma Scene #1 - Professor Dame Sally Davies
In this first episode of our new RPS Pharma Scene podcast, RPS Chief Scientist Gino Martini talks to Professor Dame Sally Davies about antimicrobial resistance (AMR), and what pharmacy can do to counter this growing threat.
About Dame Sally
Dame Sally is currently the UK Special Envoy on Antimicrobial Resistance. Before this, she was Chief Medical Officer (CMO) for England and Chief Medical Adviser to the UK government.
Dame Sally advocates globally on AMR, and has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side event in 2016.
Most recently, Dame Sally has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016.
Dame Sally was a member of the World Health Organization (WHO) Executive Board 2014-2016. She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and chaired the WHO Strategic and Technical Advisory Group on AMR for three years.
She is currently a non-executive director on the boards of: The Institute for Health Metrics and Evaluation; Genomics England Ltd; The Blavatnik School of Government, University of Oxford; The Clinton Health Access Initiative; and UK Research & Innovation. She was formerly on the boards of Cumberland Lodge and Ashridge Business School.
From 2004-2016, Dame Sally was the Chief Scientific Adviser (CSA) for the Department of Health (DH), where she was actively involved in NHS R&D from its establishment and founded the National Institute for Health Research (NIHR).
She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA in 2015.